A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death-Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma
PT-112（一种新型免疫原性细胞死亡诱导小分子）治疗复发或难治性多发性骨髓瘤的 I 期临床研究及体内研究结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2574
Kourelis, Taxiarchis; Ailawadhi, Sikander; Vogl, Dan T; Gibson, Sarah E; Sharik, Meaghen E; Du, Megan T; Ames, Tyler D; Yim, Christina Y; Baeck, Johan; Price, Matthew R; Jimeno, Jose M; Chesi, Marta; Bergsagel, P Leif
